Intrathyroid injection of dexamethasone inhibits Th2 cells in Graves’ disease

OBJECTIVE: Intrathyroid injection of dexamethasone (IID) was used for decrease the relapse rate of hyperthyroidism in the treatment of Graves’ disease (GD), but the mechanism is still unclear. We aimed to explore the effect of IID on T help (Th)1/Th2 cells and their chemokine in patients with GD. SU...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ke, Jiang, Peng, Liu, Bing-li, Liu, Xiao-mei, Mao, Xiao-ming, Hu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522220/
https://www.ncbi.nlm.nih.gov/pubmed/32555990
http://dx.doi.org/10.20945/2359-3997000000244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522220/
https://www.ncbi.nlm.nih.gov/pubmed/32555990
http://dx.doi.org/10.20945/2359-3997000000244

Ejemplares similares